Skip to main content
. 2023 May 23;78(7):1569–1585. doi: 10.1093/jac/dkad139

Figure 2.

Figure 2.

All-cause mortality rates in IC randomized trials (based on data reported by Demir).18 The figure does not account for differences in study design, namely number of patients randomized, and only includes antifungals currently reimbursed. AMB, amphotericin B; 5-Flu, 5-fluorocytosine; LAMB, lipid formulation of amphotericin B.